Fund Alloted in USD in Million Novel drug delivery systems were not only beneficial for patients, which also less complicated, non-invasive and a reduction in the dose of active ingredients.

• The global market for drug delivery systems in 2010 was $131.6 billion and is expected to increase to $137.8 billion by the end of 2011. The market is expected to rise at a compound annual growth rate (CAGR) of 5% and reach nearly $175.6 billion by 2016
• The U.S. constituted approximately 59% of the total drug delivery market in 2010 and was $78 billion. It is forecast to grow from $82 billion in 2011 to $103 billion in 2016 at a CAGR of 4.7%
• Europe contributed about 27% of the total drug delivery market in 2010 and was $36 billion. BCC expects this market to grow to $49 billion by 2016 at a CAGR of 5.6%

Audience:

• Industry       60%
• Academia     30%
• Others          10%

Universities associated with Pharmaceutica 

Figure 4:  Number of Universities

Statistics which shows growth in global revenue of advanced drug delivery systems

Figure 6: Global Revenue of Advanced Drug Delivery Systems By Region, 2011-2018 ($ Millions)